AI Portfolio Summary
In 2025 Q4, SECTOR GAMMA AS maintained a portfolio of 44 distinct positions. The most significant new addition to the portfolio was REGENERON PHARMACEUT, which now represents 1.26% of the total fund value. They heavily accumulated shares in BRISTOL-MYERS SQUIBB, increasing their position by 28.3%. Conversely, SECTOR GAMMA AS completely exited their position in ARCELLX INC.
Total Positions
44
Quarter
2025 Q4
Top Holding
BMY (9.2%)
Top 10 Concentration
55.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-44 of 44
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 9.17% | 6.50% |
#1
3
Prev: #4
|
8.2 | 164,688 | 28.3% |
P
S
|
745,955 | $40,236,813 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRK
MERCK & CO INC
|
Healthcare | 8.73% | 6.71% |
#2
1
Prev: #3
|
7.0 | 41,151 | 12.8% |
P
S
|
363,651 | $38,277,904 | 2011 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 5.90% | 7.17% |
#3
1
Prev: #2
|
3.9 | -33,797 | -11.1% |
P
S
|
269,644 | $25,902,003 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 5.86% | 5.05% |
#4
1
Prev: #5
|
5.3 | 23,547 | 21.6% |
P
S
|
132,376 | $25,690,210 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 4.94% | 4.05% |
#5
4
Prev: #9
|
4.5 | 29,175 | 19.8% |
P
S
|
176,414 | $21,653,054 | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INCY
INCYTE CORP
|
Healthcare | 4.93% | 4.31% |
#6
1
Prev: #7
|
4.0 | 13,669 | 6.7% |
P
S
|
218,783 | $21,609,197 | 2011 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PFE
PFIZER INC
|
Healthcare | 4.88% | 7.91% |
#7
6
Prev: #1
|
2.0 | -392,547 | -31.4% |
P
S
|
859,539 | $21,402,521 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMGN
AMGEN INC
|
Healthcare | 4.55% | 4.30% |
#8
Prev: #8
|
2.3 | -500 | -0.8% |
P
S
|
60,956 | $19,951,508 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 3.43% | 2.62% |
#9
3
Prev: #12
|
3.4 | 10,000 | 13.2% |
P
S
|
85,475 | $15,042,745 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 3.34% | 4.40% |
#10
4
Prev: #6
|
1.3 | -85,986 | -31.7% |
P
S
|
184,977 | $14,633,530 | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 3.21% | 2.92% |
#11
1
Prev: #10
|
3.3 | 21,397 | 13.7% |
P
S
|
177,599 | $14,094,257 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 2.90% | 2.32% |
#12
2
Prev: #14
|
1.7 | 2,410 | 4.0% |
P
S
|
61,946 | $12,729,903 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 2.86% | 2.22% |
#13
2
Prev: #15
|
3.1 | 3,244 | 17.6% |
P
S
|
21,688 | $12,567,112 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BRKR
BRUKER CORP
|
Healthcare | 2.73% | 2.02% |
#14
4
Prev: #18
|
1.6 | 3,788 | 1.5% |
P
S
|
254,697 | $11,998,776 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 2.72% | 2.77% |
#15
4
Prev: #11
|
3.1 | 19,000 | 16.7% |
P
S
|
132,478 | $11,912,422 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.69% | 2.36% |
#16
3
Prev: #13
|
3.1 | 22,653 | 12.9% |
P
S
|
198,505 | $11,797,152 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 2.60% | 0.77% |
#17
21
Prev: #38
|
4.0 | 22,943 | 238.9% |
P
S
|
32,546 | $11,409,000 | 2016 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 2.42% | 1.89% |
#18
1
Prev: #19
|
3.5 | 44,899 | 21.1% |
P
S
|
258,109 | $10,621,185 | 2012 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GEHC
GE HEALTHCARE T...
|
Healthcare | 2.14% | 2.07% |
#19
2
Prev: #17
|
1.4 | 3,000 | 2.7% |
P
S
|
114,390 | $9,382,268 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.87% | 1.41% |
#20
8
Prev: #28
|
3.2 | 23,422 | 32.1% |
P
S
|
96,402 | $8,218,271 | 2013 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTR
AVANTOR INC
|
Healthcare | 1.82% | 1.48% |
#21
5
Prev: #26
|
3.2 | 218,299 | 45.8% |
P
S
|
695,403 | $7,969,318 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIO
BIO RAD LABS IN...
|
Healthcare | 1.64% | 1.59% |
#22
1
Prev: #23
|
1.2 | 923 | 4.0% |
P
S
|
23,750 | $7,196,013 | 2013 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LH
LABCORP HOLDING...
|
Healthcare | 1.55% | 1.85% |
#23
3
Prev: #20
|
1.1 | 1,049 | 4.0% |
P
S
|
27,019 | $6,778,527 | 2009 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 1.42% | 0.82% |
#24
11
Prev: #35
|
3.1 | 29,420 | 45.7% |
P
S
|
93,823 | $6,243,921 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 1.34% | 0.81% |
#25
11
Prev: #36
|
1.0 | -2,451 | -0.9% |
P
S
|
267,091 | $5,870,660 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 1.26% | — |
#26
Prev: #—
|
4.0 | 7,165 | no change |
NEW
|
7,165 | $5,530,449 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 1.22% | — |
#27
Prev: #—
|
4.0 | 115,000 | no change |
NEW
|
115,000 | $5,353,250 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.21% | 0.80% |
#28
9
Prev: #37
|
2.5 | 41,248 | 19.6% |
P
S
|
252,062 | $5,295,823 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.15% | 1.28% |
#29
Prev: #29
|
1.0 | -699 | -0.9% |
P
S
|
76,122 | $5,052,217 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HCA
HCA HEALTHCARE ...
|
Healthcare | 1.15% | 1.15% |
#30
1
Prev: #31
|
1.0 | -99 | -0.9% |
P
S
|
10,784 | $5,034,618 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 1.08% | 0.96% |
#31
3
Prev: #34
|
0.9 | 17,426 | 4.0% |
P
S
|
455,841 | $4,736,188 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.07% | 1.80% |
#32
11
Prev: #21
|
0.4 | -56,189 | -47.6% |
P
S
|
61,923 | $4,703,671 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.79% | 1.20% |
#33
3
Prev: #30
|
0.3 | -8,022 | -33.0% |
P
S
|
16,305 | $3,476,878 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.49% | — |
#34
Prev: #—
|
3.7 | 52,039 | no change |
NEW
|
52,039 | $2,160,659 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OGN
ORGANON & CO
|
Healthcare | 0.49% | 1.44% |
#35
8
Prev: #27
|
0.2 | -243,711 | -44.8% |
P
S
|
300,000 | $2,151,000 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CERT
CERTARA INC
|
Healthcare | 0.46% | 0.70% |
#36
3
Prev: #39
|
1.2 | no change | no change |
P
S
|
230,565 | $2,031,278 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
ARCELLX INC
|
Healthcare | 0.00% | 0.65% |
Sold All 😨
(Was: #41) |
0.0 | -32,009 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BNTX
BIONTECH SE
|
Healthcare | 0.00% | 0.68% |
Sold All 😨
(Was: #40) |
0.0 | -27,732 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SOLV
SOLVENTUM CORP
|
Healthcare | 0.00% | 1.07% |
Sold All 😨
(Was: #33) |
0.0 | -59,259 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ICLR
ICON PLC
|
Healthcare | 0.00% | 1.08% |
Sold All 😨
(Was: #32) |
0.0 | -24,967 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELAN
ELANCO ANIMAL H...
|
Healthcare | 0.00% | 1.53% |
Sold All 😨
(Was: #25) |
0.0 | -307,271 | -100.0% |
CLOSED
|
— | $— | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HUM
HUMANA INC
|
Healthcare | 0.00% | 1.54% |
Sold All 😨
(Was: #24) |
0.0 | -23,942 | -100.0% |
CLOSED
|
— | $— | 2012 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTRS
VIATRIS INC
|
Healthcare | 0.00% | 1.64% |
Sold All 😨
(Was: #22) |
0.0 | -668,851 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BAX
BAXTER INTL INC
|
Healthcare | 0.00% | 2.15% |
Sold All 😨
(Was: #16) |
0.0 | -381,551 | -100.0% |
CLOSED
|
— | $— | 2012 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-44 of 44 holdings